Gemalto Brings Strong Authentication to Healthcare Industry | Gemalto
LinkedIn Login

Connect healthcare products, companies and hospitals with your LinkedIn network.

Facebook Login

Interact with your Facebook network around healthcare products, companies and hospitals.

Login With Facebook
MedicExchange Login

Enjoy Premium Access as a MedicExchange Member.

       Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Facebook Twitter Linkedin
Facebook: MedicExchange
Twitter: MedicExchange
Healthcare Company News Gemalto Gemalto Brings Strong Authentication to Healthcare Industry

Gemalto Brings Strong Authentication to Healthcare Industry

Company News - Gemalto

Gemalto become a vendor partner of SAFE-BioPharma Association

Gemalto , the world leader in digital security, announced that it has become a vendor partner of SAFE-BioPharma Association (www.safe-biopharma.org).  Gemalto is joining with biopharmaceutical and healthcare industry leaders to help the industry achieve its common goal of a fully electronic business environment by 2012.  Gemalto will contribute its expertise in smart card-based solutions for authentication, network security and digital signature. 
 
Gemalto is the first smart card provider to join SAFE-BioPharma.  Gemalto has been an active industry partner since 2004, when it began working with Pfizer to implement smart card employee badges that converge physical and logical access control onto a single identity credential.  Gemalto is also a leading supplier of smart card based solutions for healthcare identity management worldwide.
 
The SAFE-BioPharma Association, based in Fort Lee, New Jersey, is a non-profit association that created and manages the SAFE-BioPharma digital identity and signature standard for the pharmaceutical and healthcare industries. The standard provides users with a secure, enforceable, and regulatory compliant way to verify identities of parties involved in electronic transactions and to apply their digital signatures to electronic documents.
 
"We welcome Gemalto to the growing SAFE-BioPharma vendor partner community.  The company's broad experience in smart cards, digital security, digital signature and identity management for healthcare, makes it a valuable global resource for life science companies," said Mollie Shields-Uehling, president and chief executive officer, SAFE-BioPharma Association.
 
"Gemalto is a natural partner to companies using the SAFE-BioPharma standard, because we provide smart cards and tokens that serve as the secure carriers for digital identities. Two factor authentication (something you have and something you know) is an important building block for the success of many of the proposed Health IT initiatives underway in the US. For citizens to benefit from the new technologies, they need to be assured their privacy is protected,"  said François Lasnier, vice president and general manager, Security, for Gemalto North America.

Source: Gemalto

You can discuss about Gemalto and its products & services in the Gemalto Company User Group